IL2 and cancer: For example, Kanimura and colleagues have trialed IL-2/anti-IL-2 complex treatment in a mouse model of B16 melanoma [38], and Tomala and colleagues in a mouse model of BCL1 leukemia [39] as cancer immunotherapy.